Latest Clinical Evidence Presented at APWCA's Wound Week™ 2023 Illustrates the Significant and New Clinical Utility of the Molec...

Published on September 21, 2023

9/21/2023

MolecuLight Inc. announces the presentation of 6 Clinical Posters, a Presentation, and a Hands-On Workshop at the American Professional Wound Care Association's Wound Week™, held from September 20 - 24, 2023 in Philadelphia, PA.



(Feed generated with FetchRSS)
Continue reading on website
Other news

Using Predictive Intelligence to Uncover the Rare Disease Patient Journey

September 20, 2023
Using Predictive Intelligence to Uncover the Rare Disease Patient Journey jpiattWed, 09/20/2023 - 14:11

Take 3: Mesoblast plots path to market for twice-rejected cell therapy

September 21, 2023
Mesoblast has taken another step on the path toward its third attempt to win approval of its off-the-shelf therapy, exiting a meeting with the FDA convinced that new potency assay data and a single-arm trial can finally get the candidate to market.The Melbourne, Australia-based biotech wants to bring the cell therapy, remestemcel-L, to market as a treatment for steroid-refractory acute graft-versu